The downregulation or absence of MHC class I (MHC-I) molecules in HCC cells restricts the presentation of tumor antigens to CD8+ T cells, thereby preventing the immune system from effectively recognizing tumor cells [17,18]. Here, CD8A is linked to hepatocellular carcinoma.